Miller Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.2K Buy
13,782
+13,542
+5,643% +$2.91M 0.02% 31
2026
Q1
$52.2K Hold
240
0.02% 34
2025
Q4
$54.8K Hold
240
0.02% 34
2025
Q3
$55.6K Hold
240
0.02% 33
2025
Q2
$44.5K Hold
240
0.02% 31
2025
Q1
$50.3K Hold
240
0.03% 29
2024
Q4
$42.6K Hold
240
0.02% 30
2024
Q3
$45.3K Hold
240
0.02% 28
2024
Q2
$41.2K Hold
240
0.02% 32
2024
Q1
$43.7K Hold
240
0.03% 32
2023
Q4
$37.2K Hold
240
0.02% 29
2023
Q3
$35.8K Hold
240
0.02% 30
2023
Q2
$32.3K Buy
240
+140
+140% +$20.5K 0.02% 30
2023
Q1
$11K Sell
100
-400
-80% -$61.2K 0.05% 38
2022
Q4
$79K Buy
500
+250
+100% +$38.3K 0.05% 27
2022
Q3
$38K Hold
250
0.03% 42
2022
Q2
$38K Hold
250
0.03% 29
2022
Q1
$41K Hold
250
0.03% 32
2021
Q4
$34K Buy
+250
New +$29.5K 0.02% 36

Other funds holding ABBV

Miller Wealth Advisors's ABBV Position: Q2 2026 in Review

Miller Wealth Advisors increased its AbbVie (ABBV) stake by 5,643% in Q2 2026, buying an estimated $2.91M and bringing the position to 13,782 shares worth $65.2K. The position accounts for 0.02% of the portfolio, ranked #31.

Miller Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $79K in Q4 2022. 1,724 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Miller Wealth Advisors held 13,782 shares of AbbVie worth $65.2K as of Q2 2026.
  • Miller Wealth Advisors bought 13,542 AbbVie shares in Q2 2026, an estimated $2.91M.
  • AbbVie made up 0.02% of Miller Wealth Advisors's portfolio in Q2 2026, its #31 holding.
  • Miller Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Miller Wealth Advisors's AbbVie position peaked at $79K in Q4 2022.
  • 1,724 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.